- Home
- ICCM vs ANVS Comparison
ICCM vs ANVS Comparison
Compare ICCM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICCM | ANVS |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 111.3M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ICCM | ANVS |
|---|---|---|
| Price | $0.73 | $2.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $13.50 |
| AVG Volume (30 Days) | 180.6K | ★ 306.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $31.38 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $1.11 |
| 52 Week High | $1.52 | $5.50 |
Technical Indicators
Market Signals| Indicator | ICCM | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 68.80 | 56.66 |
| Support Level | $0.68 | $2.29 |
| Resistance Level | $0.74 | $2.98 |
| Average True Range (ATR) | 0.05 | 0.20 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 96.44 | 69.44 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.